Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Open-label, Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia

NCT02892422 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT02892422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02892422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Open-label, Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2016
Completion date
October 10, 2019
Enrollment
528 (actual)
Sites
102

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia